2015
DOI: 10.1016/j.tjog.2014.09.008
|View full text |Cite
|
Sign up to set email alerts
|

Safety and efficacy of thromboprophylaxis using enoxaparin sodium after cesarean section: A multi-center study in Japan

Abstract: The current study demonstrates the safety and efficacy of enoxaparin for thromboprophylaxis after C/S. Further studies are required to determine the best method of preventing asymptomatic DVT.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 23 publications
0
11
0
1
Order By: Relevance
“…Elektif sezaryen sonrası VTE insidansı 0.63/1000, acil sezaryen sonrası VTE insidansı ise 0.84/1000 olarak bildirilmiştir (17). Postpartum trombofilaksinin etkinliğini gösteren çalışmalar mevcuttur (18).…”
Section: Discussionunclassified
“…Elektif sezaryen sonrası VTE insidansı 0.63/1000, acil sezaryen sonrası VTE insidansı ise 0.84/1000 olarak bildirilmiştir (17). Postpartum trombofilaksinin etkinliğini gösteren çalışmalar mevcuttur (18).…”
Section: Discussionunclassified
“…Presently, the rate of CS, a significant risk factor for venous thromboembolism, has been steadily increasing over the past decades[1]. After CS, the incidences of PE and DVT are 0.06% and 0.04%, respectively, among the samples of the general population in Japan, which represent 22- and five-times higher risks than those after vaginal delivery[20,21]. Based on the serious risk of thrombosis, post-caesarean thromboprophylaxis has been advocated even though the evidence is still limited.…”
Section: Discussionmentioning
confidence: 99%
“…Because deep venous thrombosis may readily develop during the perioperative period of laparoscopic surgery[54], optimal thromboprophylaxis in surgical patients must consider the risks of deep venous thrombosis and bleeding complications[55]. According to the risk assessment performed in each case[55], prophylaxis for deep venous thrombosis is routinely performed not with unfractionated heparin but with low-molecular-weight heparin, such as enoxaparin sodium (Clexane; Kaken Pharmaceutical, Tokyo, Japan)[56]. …”
Section: Discussionmentioning
confidence: 99%